via Ladders
$60K - 90K a year
Oversee CMS Part D program functions, collaborate with stakeholders, manage compliance coordination, and act as subject matter expert for Part D benefits and claims.
3+ years pharmacy operations experience at health plan or PBM, strong CMS and HPMS knowledge, data analysis and Excel skills.
Job Description: • Complete oversight of all implemented CMS Part D Program functions delegated to the PBM • Collaborate with internal stakeholders for annual new and existing plan implementation as well as CMS Part D Program functions. • Coordinates with Compliance department on Part D oversight • Act as a liaison to address operational Part D issues including documenting issues, identifying owner, routing issue, gathering impact, and corrective action steps • Devoted Health Part D subject matter expert to assist internal and external partners to resolve any questions or concerns around Part D benefits and pharmacy claim adjudication through implementation and welcome season • Maintains knowledge of applicable current and proposed laws, regulations, and sub-regulatory guidance (e.g., CMS,HPMS memos) applicable to Part D specifically and general knowledge of Medicare Advantage requirements • Drafts and maintains policies and procedures, standard operating procedures, and work instructions for implementation projects Requirements: • 3 years plus experience in pharmacy operations at a health plan or pharmacy benefit manager (PBM) • Strong initiative and ability to process improve • Data analysis and strong Excel/Sheets experience • Strong understanding of CMS Guidance and HPMS(Health Plan Management System) Memo guidance updates Benefits: • Employer sponsored health, dental and vision plan with low or no premium • Generous paid time off • $100 monthly mobile or internet stipend • Stock options for all employees • Bonus eligibility for all roles excluding Director and above; Commission eligibility for Sales roles • Parental leave program • 401K program • And more....
This job posting was last updated on 12/2/2025